Gilead Sciences Canada, Inc. names Paul Petrelli as VP and General Manager in Canada

PAUL PETRELLI, VICE PRESIDENT & GENERAL MANAGER IN CANADA (CNW Group/Gilead Sciences Canada)

MISSISSAUGA — Gilead Sciences Canada, Inc. (Gilead Canada) announced that Paul Petrelli joined the organization as Vice President and General Manager. In his new role, Petrelli will be responsible for leading the commercial organization for Gilead Canada, with a focus on expanding access to Gilead’s therapies and driving sustainable growth.

Petrelli has experience in the Canadian biotech industry with a background in supporting people development, and leading teams in diverse markets including in Canada, Europe, and the US. He reportedly brings a work history across nearly every aspect of the pharmaceutical sector, including product lifecycle management and an understanding of sales, marketing, market access, medical, government relations, regulatory and more.

Prior to joining Gilead Canada, Paul most recently led Jazz Pharmaceuticals, where he was involved in building their Canadian organization over the past 7 years. His prior commercial experience also includes increasingly senior commercial roles at GSK, AstraZeneca and Biogen.

“It’s a privilege to join an organization that’s been at the forefront of groundbreaking scientific and societal progress, with a strong legacy in transforming lives through innovations in viral hepatitis, and HIV,” said Petrelli. “Partnerships continue to be a key focus for me and for Gilead Canada. We share the same priorities of our community, medical, academic and government partners, and I’m excited to deepen our relationships to make meaningful impact for Canadians across all our therapeutic areas.”

Petrelli is based at Gilead Canada’s head office in Mississauga, Ontario.